Evidence map›Paper›PMID 28740095›Full record

ArticleScientific reports2017

Phylodynamics of major CRF01_AE epidemic clusters circulating in mainland of China.

Xiaolin Wang, Xiang He, Ping Zhong, Yongjian Liu, Tao Gui, Dijing Jia, Hanping Li, Jianjun Wu, Jin Yan, Dianmin Kang and 22 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Xiaolin WangDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Xiang HeGuangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, 511430, China.
Ping ZhongShanghai Municipal Center for Diseases Control and Prevention, Shanghai, 200336, China.
Yongjian LiuDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Tao GuiThe 59th hospital of PLA, Kaiyuan, Yunnan, 661600, China.
Dijing JiaAnhui Medical University, Hefei, Anhui, 230032, China.
Hanping LiDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Jianjun WuAnhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, 230601, China.
Jin YanGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, 511430, China.
Dianmin KangInstitute of AIDS Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, Shandong, 250014, China.
Yang HanDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100032, China.
Taisheng LiDepartment of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100032, China.
Rongge YangResearch Group of HIV Molecular Epidemiology and Virology, Center for Molecular Virology, The State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China.
Xiaoxu HanKey Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Lin ChenShenzhen Municipal Center for Disease Control and Prevention, Shenzhen, Guangdong, 518055, China.
Jin ZhaoShenzhen Municipal Center for Disease Control and Prevention, Shenzhen, Guangdong, 518055, China.
Hui XingState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention (NCAIDS), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Shu LiangSichuan provincial center for disease control and prevention, Chengdu, Sichuan, 610041, China.
Jianmei HeHunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, 410005, China.
Yansheng YanFujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian, 350001, China.
Yile XueShanghai Municipal Center for Diseases Control and Prevention, Shanghai, 200336, China.
Jiafeng ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310051, China.
Xun ZhuangSchool of Public Health, Nantong University, Nantong, Jiangsu, 226019, China.
Shujia LiangGuangxi Center for Disease Prevention and Control, Nanning, Guangxi, 530028, China.
Zuoyi BaoDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Tianyi LiDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Daomin ZhuangDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Siyang LiuDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Jingwan HanDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Lei JiaDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China. lijy@bmi.ac.cn.
Jingyun LiDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Lin LiDepartment of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China. dearwood@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the most dominant HIV-1 strain in China, CRF01_AE needs to have its evolutionary and demographic history documented. In this study, we provide phylogenetic analysis of all CRF01_AE pol sequences identified in mainland China. CRF01_AE sequences were collected from the Los Alamos HIV Sequence Database and the local Chinese provincial centers of disease control and prevention. Phylogenetic trees were constructed to identify major epidemic clusters. Bayesian coalescent-based method was used to reconstruct the time scale and demographic history. There were 2965 CRF01_AE sequences from 24 Chinese provinces that were collected, and 5 major epidemic clusters containing 85% of the total CRF01_AE sequences were identified. Every cluster contains sequences from more than 10 provinces with 1 or 2 dominant transmission routes. One cluster arose in the 1990s and 4 clusters arose in the 2000s. Cluster I is in the decline stage, while the other clusters are in the stable stage. Obvious lineage can be observed among sequences from the same transmission route but not the same area. Two large clusters in high-level prevalence were found in MSM (Men who have sex with men), which highlighted that more emphasis should be placed on MSM for HIV control in mainland China.

Indexed as

Bayes TheoremChinaEvolution, MolecularHIV-1HIV InfectionsHumansMaleMolecular EpidemiologyPhylogenyPhylogeographypol Gene Products, Human Immunodeficiency VirusSequence Analysis, RNApol Gene Products, Human Immunodeficiency Virus

Identifiers

PMID28740095
PMCPMC5524839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.